Bausch Health Cos Long Term Debt 2010-2024 | BHC
Bausch Health Cos long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Bausch Health Cos Annual Long Term Debt (Millions of US $) |
2023 |
$21,938 |
2022 |
$20,334 |
2021 |
$22,654 |
2020 |
$23,925 |
2019 |
$24,661 |
2018 |
$24,077 |
2017 |
$25,235 |
2016 |
$29,845 |
2015 |
$30,265 |
2014 |
$15,228 |
2013 |
$17,163 |
2012 |
$10,535 |
2011 |
$6,540 |
2010 |
$3,478 |
2009 |
$314 |
Bausch Health Cos Quarterly Long Term Debt (Millions of US $) |
2024-09-30 |
$21,054 |
2024-06-30 |
$21,208 |
2024-03-31 |
$21,536 |
2023-12-31 |
$21,938 |
2023-09-30 |
$21,894 |
2023-06-30 |
$20,108 |
2023-03-31 |
$20,207 |
2022-12-31 |
$20,334 |
2022-09-30 |
$20,804 |
2022-06-30 |
$21,664 |
2022-03-31 |
$23,168 |
2021-12-31 |
$22,654 |
2021-09-30 |
$22,358 |
2021-06-30 |
$23,439 |
2021-03-31 |
$23,738 |
2020-12-31 |
$23,925 |
2020-09-30 |
$24,343 |
2020-06-30 |
$24,357 |
2020-03-31 |
|
2019-12-31 |
$24,661 |
2019-09-30 |
$23,466 |
2019-06-30 |
$24,023 |
2019-03-31 |
$23,924 |
2018-12-31 |
$24,077 |
2018-09-30 |
$24,433 |
2018-06-30 |
$24,858 |
2018-03-31 |
$25,266 |
2017-12-31 |
$25,235 |
2017-09-30 |
$26,216 |
2017-06-30 |
$27,648 |
2017-03-31 |
$28,198 |
2016-12-31 |
$29,845 |
2016-09-30 |
$30,386 |
2016-06-30 |
$30,773 |
2016-03-31 |
$31,303 |
2015-12-31 |
$30,265 |
2015-09-30 |
$30,176 |
2015-06-30 |
$30,290 |
2015-03-31 |
$25,898 |
2014-12-31 |
$15,228 |
2014-09-30 |
$15,584 |
2014-06-30 |
$17,059 |
2014-03-31 |
$17,148 |
2013-12-31 |
$17,163 |
2013-09-30 |
$17,044 |
2013-06-30 |
$10,447 |
2013-03-31 |
$10,327 |
2012-12-31 |
$10,535 |
2012-09-30 |
$7,423 |
2012-06-30 |
$7,356 |
2012-03-31 |
$6,851 |
2011-12-31 |
$6,540 |
2011-09-30 |
$5,188 |
2011-06-30 |
$4,529 |
2011-03-31 |
$4,699 |
2010-12-31 |
$3,478 |
2010-09-30 |
$3,114 |
2010-06-30 |
$303 |
2010-03-31 |
$317 |
2009-12-31 |
$314 |
2009-09-30 |
|
2009-06-30 |
|
2009-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$2.672B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|